| 000 | 01719 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516141552.0 | ||
| 264 | 0 | _c20130808 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a0006-3002 | ||
| 024 | 7 |
_a10.1016/j.bbamem.2013.03.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAgelis, G | |
| 245 | 0 | 0 |
_aInteractions of the potent synthetic AT1 antagonist analog BV6 with membrane bilayers and mesoporous silicate matrices. _h[electronic resource] |
| 260 |
_bBiochimica et biophysica acta _cAug 2013 |
||
| 300 |
_a1846-55 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xpharmacology |
| 650 | 0 | 4 | _aCalorimetry, Differential Scanning |
| 650 | 0 | 4 |
_aCell Membrane _xmetabolism |
| 650 | 0 | 4 | _aDrug Delivery Systems |
| 650 | 0 | 4 |
_aLipid Bilayers _xmetabolism |
| 650 | 0 | 4 |
_aLosartan _xpharmacology |
| 650 | 0 | 4 | _aMagnetic Resonance Spectroscopy |
| 650 | 0 | 4 |
_aOligopeptides _xpharmacology |
| 650 | 0 | 4 |
_aReceptor, Angiotensin, Type 1 _xchemistry |
| 650 | 0 | 4 |
_aSilicon Dioxide _xmetabolism |
| 650 | 0 | 4 | _aSpectrum Analysis, Raman |
| 650 | 0 | 4 | _aThermogravimetry |
| 650 | 0 | 4 | _aX-Ray Diffraction |
| 700 | 1 | _aResvani, A | |
| 700 | 1 | _aNtountaniotis, D | |
| 700 | 1 | _aChatzigeorgiou, P | |
| 700 | 1 | _aKoukoulitsa, C | |
| 700 | 1 | _aAndroutsou, M E | |
| 700 | 1 | _aPlotas, P | |
| 700 | 1 | _aMatsoukas, J | |
| 700 | 1 | _aMavromoustakos, T | |
| 700 | 1 | _aCendak, T | |
| 700 | 1 | _aGodec, T Ukmar | |
| 700 | 1 | _aMali, G | |
| 773 | 0 |
_tBiochimica et biophysica acta _gvol. 1828 _gno. 8 _gp. 1846-55 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.bbamem.2013.03.009 _zAvailable from publisher's website |
| 999 |
_c22593567 _d22593567 |
||